Concepedia

Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Gu�rin immunotherapy for carcinoma in situ of the bladder

Etsuya Watanabe, Hideyasu Matsuyama, Kenji Matsuda, Chietaka Ohmi, Yasuhide Tei, Satoru Yoshihiro, Yasukazu Ohmoto, Katsusuke Naito

Cancer Immunology Immunotherapy · 2003 · 89 citations · 29 references

DOIFull text

Open access

Concepts

References

29

Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors

Álvaro Morales, David Eidinger, Andrew W. Bruce · The Journal of Urology · 2016 · 1.5K citations

, , +5

Intracavitary bacillus Calmette-Grerin in the treatement of superficial bladder tumors

A Morales · The Journal of Urology · 1976 · 978 citations

, , +14

LONG-TERM RESULTS OF INTRAVESICAL THERAPY FOR SUPERFICIAL BLADDER CANCER

Donald L. Lamm · Urologic Clinics of North America · 1992 · 282 citations

, , +9

Intravesical Evans Strain BCG Therapy: Quantitative Immunohistochemical Analysis of the Immune Response within the Bladder Wall

Steven A. Prescott, K. James, T. B. Hargreave et al. · The Journal of Urology · 1992 · 219 citations

, , +17

Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer

Elizabeth C. de Boer, Wim H. de Jong, P. A. Steerenberg et al. · Cancer Immunology Immunotherapy · 1992 · 201 citations · Full text

, , +14